These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

153 related items for PubMed ID: 1716800

  • 1. Enhancement of allograft survival by donor-specific transfusion one day prior to transplant. Importance of timing and specificity when DST is given with cyclosporine.
    Brunson ME, Tchervenkov JI, Alexander JW.
    Transplantation; 1991 Sep; 52(3):545-9. PubMed ID: 1716800
    [Abstract] [Full Text] [Related]

  • 2. The effect of donor-specific blood transfusion, cyclosporine, and dietary prostaglandin precursors on rat cardiac allograft survival. II. Effectiveness of a 24-hour induction period with DST and CsA in inducing long-term graft survival.
    Tchervenkov JI, Epstein MD, Alexander JW, Schroeder TJ.
    Transplantation; 1989 Jan; 47(1):177-81. PubMed ID: 2643225
    [Abstract] [Full Text] [Related]

  • 3. Effect of ultraviolet-B-irradiated donor-specific blood transfusions and peritransplant immunosuppression with cyclosporine on rat cardiac allograft survival.
    Oluwole SF, Lau HT, Reemtsma K, Hardy MA.
    Transplantation; 1988 Feb; 45(2):293-7. PubMed ID: 3278417
    [Abstract] [Full Text] [Related]

  • 4. Indefinite allograft survival induced by the combination of multiple donor-specific transfusions, cyclosporine, and an anti-T cell monoclonal antibody in a protocol relevant to cadaveric organ transplantation. The importance of prolonged posttransplant cyclosporine coverage.
    Tchervenkov JI, Cofer BR, Davies C, Alexander JW.
    Transplantation; 1995 Mar 27; 59(6):821-4. PubMed ID: 7701575
    [Abstract] [Full Text] [Related]

  • 5. Pretransplant conditioning with donor-specific transfusions using heated blood and cyclosporine. Preservation of the transfusion effect in the absence of sensitization.
    Martinelli GP, Horowitz C, Chiang K, Racelis D, Schanzer H.
    Transplantation; 1987 Jan 27; 43(1):140-5. PubMed ID: 3541314
    [Abstract] [Full Text] [Related]

  • 6. The significance of timing of additional short-term immunosuppression in the donor-specific transfusion/cyclosporine-treated rat.
    Levy AE, Alexander JW.
    Transplantation; 1996 Jul 27; 62(2):262-6. PubMed ID: 8755826
    [Abstract] [Full Text] [Related]

  • 7. Effect of a short course of rapamycin, cyclosporin A, and donor-specific transfusion on rat cardiac allograft survival.
    Davies CB, Madden RL, Alexander JW, Cofer BR, Fisher RA, Anderson P.
    Transplantation; 1993 May 27; 55(5):1107-12. PubMed ID: 8497890
    [Abstract] [Full Text] [Related]

  • 8. Rapamycin, cyclosporine, and perioperative donor-specific transfusions induce prolongation of cardiac allograft survival in the rat.
    Knight RJ, Polokoff EG, Martinelli GP.
    Transplantation; 1994 Nov 15; 58(9):1014-20. PubMed ID: 7974728
    [Abstract] [Full Text] [Related]

  • 9. Induction of donor-specific unresponsiveness to rat cardiac allograft by donor leukocytes and cyclosporine.
    Oluwole SF, Fawwaz RA, Reemtsma K, Hardy MA.
    Transplantation; 1988 Jun 15; 45(6):1131-5. PubMed ID: 3289153
    [Abstract] [Full Text] [Related]

  • 10. Effects of pre- and postengraftment donor-specific transfusions and cyclosporine on the enhancement of experimental allograft survival.
    Cofer BR, Davies CB, Alexander JW, Tchervenkov JI, Fisher RA.
    J Surg Res; 1992 Jun 15; 52(6):663-7. PubMed ID: 1528044
    [Abstract] [Full Text] [Related]

  • 11. The effect of nutritional immunomodulation on cardiac allograft survival in rats receiving mycophenolate mofetil, cyclosporine A, and donor-specific transfusion.
    Gibson SW, Valente JF, Alexander JW, Custer DA, Babcock GF, Ogle CK.
    J Heart Lung Transplant; 1999 Mar 15; 18(3):185-9. PubMed ID: 10328142
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Small bowel transplantation in the rat. Effect of pretransplant blood transfusions and cyclosporine on host survival.
    Martinelli GP, Knight RK, Kaplan S, Racelis D, Dikman SH, Schanzer H.
    Transplantation; 1988 Jun 15; 45(6):1021-6. PubMed ID: 3260047
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Mechanisms of immunologic unresponsiveness induced by ultraviolet-irradiated donor-specific blood transfusions and peritransplant cyclosporine.
    Oluwole SF, Chabot J, Pepino P, Reemtsma K, Hardy MA.
    Transplantation; 1988 Sep 15; 46(3):352-8. PubMed ID: 2971279
    [Abstract] [Full Text] [Related]

  • 16. Minimal sensitization and excellent renal allograft outcome following donor-specific blood transfusion with a short course of cyclosporine.
    Cheigh JS, Suthanthiran M, Fotino M, Riggio RR, Schechter N, Stubenbord WT, Stenzel KH, Rubin AL.
    Transplantation; 1991 Feb 15; 51(2):378-81. PubMed ID: 1825244
    [Abstract] [Full Text] [Related]

  • 17. Prolactin suppression enhances the effects of perioperative donor-specific blood transfusions on graft survival.
    Martinelli GP, Liu H, Clarke WP, Heisenleder DJ, Knight RJ.
    J Surg Res; 1996 Aug 15; 64(2):190-7. PubMed ID: 8812632
    [Abstract] [Full Text] [Related]

  • 18. Nutritional immunomodulation enhances cardiac allograft survival in rats treated with donor-specific transfusion and cyclosporine.
    Levy AE, Alexander JW.
    Transplantation; 1995 Oct 27; 60(8):812-5. PubMed ID: 7482740
    [Abstract] [Full Text] [Related]

  • 19. The effect of donor-specific transfusions on rat heart allograft survival.
    Johnson CP, Munda R, Alexander JW, Balakrishnan K, Blanton M.
    Transplantation; 1984 Dec 27; 38(6):575-8. PubMed ID: 6390816
    [Abstract] [Full Text] [Related]

  • 20. Arginine, fish oil, and donor-specific transfusions independently improve cardiac allograft survival in rats given subtherapeutic doses of cyclosporin.
    Alexander JW, Levy A, Custer D, Valente JF, Babcock G, Ogle CK, Schroeder TJ.
    JPEN J Parenter Enteral Nutr; 1998 Dec 27; 22(3):152-5. PubMed ID: 9586793
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.